-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Dementia doesn't actually refer to a specific disease, but a medical term to describe a group of symptoms with "decreased memory, thinking, and social abilities
.
" According to WHO statistics, there are more than 55 million dementia patients worldwide, with nearly 10 million new cases every year
Dementia
Memory loss is the most common early symptom of dementia, and earlier identification of those at risk of developing dementia could help prioritize interventions to prevent the disease from progressing
.
However, identifying patients at high risk of dementia remains a challenge for clinicians.
Recently, researchers from the University of Exeter Medical School in the United Kingdom published a research paper titled: Performance of Machine Learning Algorithms for Predicting Progression to Dementia in Memory Clinic Patients in JAMA Network Open, a sub-journal of JAMA
.
.
The research developed a machine-learning clinical decision aid that can uncover hidden patterns in examination data, analyze people at high risk of developing dementia in the next 2 years in memory clinics, and help reduce clinical misdiagnosis rates of dementia
.
For dementia, there are two clinical decision aids available to assist in assessing the medium- and long-term incidence of dementia in different populations
.
Among them, the Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) risk score is designed to predict the risk of dementia in middle-aged people after 20 years, and the Brief Dementia Screening Index (Brief Dementia Screening Indicator, BDSI) was designed to predict the risk of dementia 6 years later in elderly patients
The study included 15,307 patients who visited memory clinics of more than 30 National Alzheimer's Coordinating Centers (NACC) in the United States between 2005 and 2015
.
These patients do not yet have dementia, although they have some problems with memory and brain function
The data showed that 1 in 10 memory clinic patients (1568) were diagnosed with dementia within the next two years during the study time frame from 2005 to 2015
.
Machine learning can work efficiently, using patient information routinely provided in the clinic, such as memory and brain function, performance on cognitive tests and specific life>
The researchers also found for the first time that about 8 percent (130 people) of dementia diagnoses appeared to be wrong because their diagnoses were later overturned, yet machine learning models were able to identify these inconsistent diagnoses to a large extent
.
"This is the first analysis of potential misdiagnoses in the NACC Uniform Data Set (UDS), and machine learning as a clinical decision aid has the potential to reduce false positives by up to 84%," the team said
Study co-author Dr Janice Ranson, a researcher at the University of Exeter, added: "Dementia is a very frightening disease
.
Embedding machine learning in memory clinics could help ensure diagnoses are more accurate and less likely to be misdiagnosed.
The team now plans to conduct follow-up studies to assess the practical use of the machine learning approach in the clinic to assess whether it can be generalized to improve dementia diagnosis, treatment and care
Original source:
Original source:Charlotte James, et al.
Performance of Machine Learning Algorithms for Predicting Progression to Dementia in Memory Clinic Patients .
JAMA Netw Open.
2021;4(12):e2136553.